ETON

ETON PHARMACEUTICALS INC

ETON·29772L108·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

ETON (ETON PHARMACEUTICALS INC) is held by 91 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($68.6M), VANGUARD CAPITAL MANAGEMENT LLC ($35.4M), MORGAN STANLEY ($27.8M). Net institutional sentiment: Bullish.

91
Holders
(7 Elite)
$353.4M
Total Value
78% (88)
Consensus
69 buying - 19 selling
13F: Insider & Congress: Updated regularly
ETON

Smart Money Verdict

View all
Loading verdict
Held by 91 funds
7 elite

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Oct 6, 2026 · Activists Jul 28, 2026 · Congress none

InsiderKDKrempa DavidSell $229KOct 6, 2026
InsiderKDKrempa DavidExercise 11K shOct 2, 2026
InsiderMVMAIER PAUL VSell $8KAug 28, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
1.9M(+10.4%)$68.6M0.0%+227.59%
33
Decreased
976,570(-1.8%)$35.4M0.0%+123.87%
0
Increased
767,972(+60.7%)$27.8M0.0%+140.76%
41
Increased
701,786(+32.4%)$25.4M0.0%+169.41%
37
Increased
652,303(+12.9%)$23.6M0.0%+305.76%
32
Increased
375,707(+548.3%)$13.6M0.0%+68.37%
45
Increased
322,466(+6.7%)$11.7M0.0%+176.78%
30
Increased
310,879(+82.1%)$11.3M0.0%+101.00%
43
Increased
255,849(+7.6%)$9.3M0.0%+290.67%
30
Increased
249,182(+201.2%)$9M0.0%+70.65%
44
Increased
194,591(+28.2%)$7M0.0%+103.00%
34
Increased
191,635(+12.8%)$7M0.0%+199.22%
31
New
188,452$6.8M0.0%+52.62%
38
Increased
185,697(+94.6%)$6.7M0.0%+88.19%
43
Increased
168,539(+2.3%)$6.1M0.0%+121.52%
28
Decreased
142,257(-1.5%)$5.1M0.0%+183.01%
0
Decreased
132,583(-39.0%)$4.8M0.0%+213.78%
0
Increased
118,249(+6.3%)$4.3M0.0%+413.29%
29
Increased
116,291(+9.3%)$4.2M0.0%+178.33%
29
Increased
114,655(+1099.5%)$4.2M0.0%+60.03%
43

Showing 1-20 of 91

1 / 5
ETONETONETON PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used